Focus: Moon Surgical is a Series A surgical robotics company developing the Maestro Platform for laparoscopic surgery. The company operates at pre-commercial scale with 1–50 employees.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Best fit for technical founders, surgical robotics specialists, or early-stage operators willing to bet on an unproven platform in exchange for outsized equity upside and functional control.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Moon Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Moon Surgical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles